SAN DIEGO — Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the […]
DKSH will utilize its market expansion expertise to introduce Countstar’s innovative cell analysis systems into Malaysia, driving growth in the life sciences and biopharma sectors with cutting-edge technology and comprehensive distribution services. Petaling Jaya, Malaysia – DKSH Business Unit Technology has formed a partnership with Countstar, a leading cell analysis solutions provider, in Malaysia. The […]
Palo Alto, California – Just as the transistor and microscope unlocked new waves of discovery, today, GenBio AI opens the doors to a new era of scientific exploration with Phase 1 of the world’s first AI-Driven Digital Organism (AIDO). In this first phase, scientists will have access to not one, but six groundbreaking models that […]
Partnership helps expand population access to cutting-edge genomic tests SAO PAULO — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, has recently partnered with Sabin Group, one of the largest diagnostic laboratories in Brazil, to improve health detection through genetic sequencing technology. The […]
Proprietary Next-Generation Non-Viral, Non-Electroporative Transfection Platform Gaining Traction in Cell Therapy Market ALAMEDA, Calif.–CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing tools, today announced several strategic system placements with major pharmaceutical and biotech companies, as well as leading translational medicine centers in the cell therapy market. These placements follow the successful […]
Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next generation products Anil Narasimha, Ph.D. joins as Chief Commercial Officer CAMBRIDGE, Mass.–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform […]
Partnership Expands Access to Scalable, High-Quality Single Cell Analysis for Researchers SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier provider of Next-Generation Sequencing services for researchers worldwide, has been certified as part of Parse’s Certified Service Provider (CSP) program. […]
BOSTON–Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures. The combined solution will help scientists measure critical process parameters in bioreactors, offering continuous, real-time analysis without the need for manual sampling. In the field […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes. The companies plan to combine their complementary expertise on charge separation (Bio-Techne’s MauriceFlex™ System) and liquid chromatography mass spectrometry […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
